Prestige Consumer Healthcare (PBH) Cost of Revenue (2010 - 2025)

Prestige Consumer Healthcare's Cost of Revenue history runs 16 years deep, the most recent figure standing at $126.1 million for Q4 2025.

• In Q4 2025, Cost of Revenue fell 1.01% year-over-year to $126.1 million; the TTM figure through Dec 2025 stood at $484.3 million (down 2.25% YoY), while the FY2025 annual figure was $503.3 million, up 2.13% from the prior year.
• Cost of Revenue was $126.1 million for Q4 2025 at Prestige Consumer Healthcare, up from $122.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $130.3 million in Q1 2023 to a low of $105.3 million in Q1 2021.
• Historically, Cost of Revenue has averaged $121.1 million across 5 years, with a median of $122.9 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Cost of Revenue grew 19.69% in 2021, then dropped 8.0% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $117.6 million in 2021, then gained by 6.39% to $125.1 million in 2022, then dropped by 1.86% to $122.8 million in 2023, then climbed by 3.72% to $127.4 million in 2024, then fell by 1.01% to $126.1 million in 2025.
• The last three Cost of Revenue figures came in at $126.1 million (Q4 2025), $122.5 million (Q3 2025), and $109.2 million (Q2 2025), per Business Quant data.